MHCII molecules are heterodimeric cell surface proteins composed of an a and b chain. These molecules are almost exclusively expressed on thymic epithelium and antigen presenting cells (APCs) and play a central role in the development and function of CD4 T cells. Various MHC-II knockout mice have been generated including MHC-IIAa -/-
Introduction
The interplay between the innate and the adaptive arms of the immune system is essential for the establishment of protective immunity against harmful microbial infections. This protective immunity involves differential recognition of infectious non-self antigens. CD4
+ T cells, part of the adaptive immune response, play a major role in orchestrating both humoral and cell-mediated immunity. Importantly, helper and regulatory functions of CD4 + T cells involve antigen recognition through their TCRs, which recognize processed peptide antigens presented by antigen presenting cells (APCs) in the context of major histocompatibility complex class II (MHC-II) molecules. Therefore, MHC-II molecules play a central role in the development and function of the immune system. Expression of MHC-II genes is tightly regulated and mostly restricted to thymic epithelium [1, 2] and APCs [3, 4] . MHC-II molecules are heterodimeric proteins and there are two isotypic forms (I-A and I-E) expressed in mice. Each isotypic form is composed of an a and b chain (Aa:Ab and Ea:Eb, respectively). Thus, any strategy to generate MHC-II-deficient (MHC-II -/-) mice requires the elimination of both I-A and I-E expression. It is fortunate that H-2 b mice (such as C57BL6/J mice) have a deletion in their Ea gene, resulting in their inability to produce Ea proteins [5] . As the pairing of both chains is required for stable cell surface expression, H-2 b mice lack I-E expression. It follows that disruption of either Aa or Ab gene locus does prevent the cell surface expression of I-A molecules. For the purposes of understanding MHC-II function in mice, several H-2 b strains completely defective in MHC-II expression have been generated by targeted disruption of the Ab gene (I-Ab -/-) [1, 6] , the Aa gene (I-Aa -/-) [7] and by deletion of both the Aa and Ab locus (IAaxb -/-) [8] . Using one or other of these ko strains, the function of MHC-II molecules in immune responses has been investigated over the past twenty years. Most studies have used I-Ab -/-mice to examine the role of MHC-II in the response to virus infection, such as influenza [9] [10] [11] , LCM [12] [13] [14] , Theiler [15, 16] , Vaccinia [17] , and Sendai [18] . I-Aa -/-mice have only been referred to in two research articles investigating ectromelia (ECT) virus (orthopoxvirus) [19] and Lassa virus infection [20] . Despite defective Ab-isotype switching, these studies did not report marked increases in susceptibility to viral infections. Here we report that avirulent SFV (aSFV), which only causes asymptomatic infection in adult wild-type C57BL6/J (B6) mice, caused a very acute and lethal infection in I-Aa -/-mice. We found this susceptibility to be unrelated to the lack of functional MHC-II expression, but associated with increased virus replications in various tissues. Such increased virus susceptibility appears to be associated with viral infections in general.
Results and Discussion
The absence of functional MHC-II molecule expression in IAa -/-mice was demonstrated by a lack of cell surface expression of MHC-II and antibody isotype response to inactivated viruses (figure 1). Splenocytes from B6 and I-Aa -/-mice were stained for their cell surface expression of CD19 and I-Ab and analysed by FACS. Our data show high expression levels of MHC-II molecules on CD19+ cells from B6 mice compared to that from I-Aa -/-mice ( Figure 1a ). In addition, we injected both wild type and I-Aa -/-mice with gamma-ray inactivated SFV (1610 6 equivalent pfu/ mouse) intravenously (i.v). Serum samples collected at days 3, 6, 9, 12, 15 and 21 post vaccination were tested for anti-SFV antibody responses and their isotypes were determined. The data show that antibody responses in I-Aa -/-mice, in contrast to that of B6 mice, are restricted to IgM (Figure 1b) . Overall, our data confirm the phenotype of I-Aa -/-mice in terms of inability to antibody isotype switching and lack of MHC-II expression.
Susceptibility of I-Aa
-/-mice to aSFV infections 10-week-old female mice (10 mice/group) were infected i.v with 10 3 or 10 7 pfu/mouse of aSFV and survival of animals was monitored for a period of 21 days. aSFV is known to cause asymptomatic infection in B6 mice [21] , and consistent with this no mortality was observed (Figure 2a ). In contrast, 100% mortality occurred in I-Aa -/-mice even with the low (10 3 PFU) infection dose with a mean time to death of,4 days.
We next investigated the susceptibility of I-Ab -/-mice [6] and the double knockout I-Aaxb -/-mice [8] to aSFV infection. Again, 10-week-old female mice were infected i.v with aSFV (10 7 pfu/ mouse) and survival of infected animals was monitored for 21 days. In contrast to I-Aa -/-mice, no mortality was observed in either IAb -/-or I-Aaxb -/-mice following aSFV infection ( Figure 2b ). In general, despite the complete deletion of MHC-II locus in IAaxb -/-mice, infection with aSFV was asymptomatic. Considering that I-Aaxb -/-mice lack the I-Aa chain, our data suggests that I-Aa -/-mice susceptibility to aSFV infection is not a consequence of the lack of MHC-II expression and their associated function. To eliminate the possibility that I-Aa -/-mice express a Mendelian dominant inheritance feature conferring susceptibility, we crossbreed I-Aa -/-and I-Ab -/-mice and infected females of the F1 generation with aSFV (10 7 pfu/mouse). As expected, F1 mice behaved like wild-type mice and no mortality was observed as a result of aSFV infection (Figure 2b ).
Susceptibility of I-Aa -/-mice to virus infection is not determined by cells of haemopoietic origin
To understand the difference between aSFV infection in B6 and I-Aa -/-mice, we determined virus titres in brain, liver, spleen and serum at days 1 and 2 post-infection. Mice were infected i.v with 10 3 pfu of aSFV and virus titres were determined using plaque assay and expressed as pfu/g of brain, liver and spleen, or pfu/ml for serum. As shown in figure 3 , I-Aa -/-mice show high levels of viremia, 200 and 400 folds above titres detected in B6 mice at days 1 and 2 post-infection, respectively. This increase in viremia is associated with high virus load in all tissues tested. Statistical analysis using unpaired student t test show a significant difference between B6 and I-Aa -/-mice in virus titres with P,0.05 for all tested time points for serum, spleen and liver samples as well as brain samples tested at day 2 post infection.
Considering that MHC-II gene expression is tightly regulated and mostly restricted to cells of reticulo-endothelial origin such as thymic epithelium and APCs [1, 2] including B cells, we investigated if somatic or haematopoietic cells are involved in the susceptibility of I-Aa -/-mice to aSFV infection. Females B6 and I-Aa -/-mice at 6 weeks of age were irradiated with 950 Rad of gamma-rays using a 137 Cs source at CSIRO-Canberra. Irradiated mice were reconstituted, as previously described, using 5610 6 bone marrow cells from female donors (either B6 or I-Aa -/-) instead of foetal liver [22] . Bone marrow chimeras were treated with antibiotics for 3 weeks post-reconstitution. Successful establishment of chimeric mice was confirmed by FACS analysis of cell surface expression of MHC-II on CD19 + cells (data not shown). 5 weeks post-reconstitution, fully chimeric mice were injected i.v with 10 3 pfu/mouse of aSFV and tissue virus titers tested 1 day post infection using plaque assays. As shown in figure 4 , various tissues from irradiated recipient I-Aa -/-mice show high virus titres regardless of the genotype of the transferred bone marrow (whether B6 or I-Aa -/-) following aSFV infection whereas B6 recipients expressed wt phenotype irrespective of donor bone marrow origin.
IFN-I response in I-Aa -/-mice
The early mortality following aSFV infection in I-Aa -/-mice and the increased tissue virus titres led us to investigate the possibility of a defective IFN-I response in I-Aa -/-mice. Therefore, sera samples were collected from mice infected with 10 7 pfu/ mouse aSFV and tested for IFN-a levels. As shown in figure 5A, higher levels of IFN-I a were detected 24 h post aSFV infection in serum samples from I-Aa -/-mice compare to B6 mice. Thus the increased viral susceptibility of I-Aa -/-mice is not due to a defective IFN-I a response and the heightened IFN-I release in IAa -/-mice is consistent with the heightened viremia in I-Aa -/-mice.
We next examined the cell surface expression of IFN-I receptors and found that both wt B6 and I-Aa -/-mice express similar levels Figure 5B). We have previously reported a phenomenon of IFN-I mediated partial lymphocyte activation during acute viral infection and have illustrated the essential role of IFN-I receptors in this phenomenon [23] . To address the functionality of IFN-I receptors in I-Aa -/-mice, we treated splenocytes from B6, I-Aa -/-, and IFN-IR -/-mice with 1000 U/ml of recombinant IFN-I (r-IFN-b). Following incubation in vitro for 12 h. Cell surface expression of CD69 and CD25 was evaluated using FACS. As shown in figure 5C , splenocytes from both B6 and I-Aa -/-, in contrast to IFN-IR -/-, mice show increased expression levels of CD69 and CD25 on B220+ cells following treatment with rIFN-b. This illustrates the fact that I-Aa -/-mice have functional IFN-I receptors. Importantly, IFN-I mediated anti-viral immunity involves various signalling pathways and mice defective in STAT1, for example, have been shown to be susceptible to viral infections [24] . Unlike previously published work regarding STAT1 -/-mice, cells of I-Aa -/-mice are responsive to IFN-I treatment as evident by the induction of CD69 expression ( figure 5B) . Overall, our data show that the increased susceptibility of I-Aa -/-mice to aSFV infection is neither associated with a lack of IFN-I secretion nor a defective IFN-I receptor function. To further study this phenomenon of increased viral susceptibility, we investigated the possibility of enhanced viral replication per se using in vitro cultures of macrophages, splenocytes and fibroblasts.
High level of viral replication in vitro
B6 wt and I-Aa -/-mice were injected i.p with thioglycollate (1 ml/mouse) and three days later, peritoneal macrophages and splenocytes collected. 1610 6 nucleated cells were infected with aSFV at a MOI of 0.5 pfu/cell. Virus replication in tissue cultures was estimated 24 and 48 hours later by plaque assay. As shown in figure 6A , significantly higher SFV replication was found in splenocyte and macrophage cultures derived from I-Aa -/-mice than that from B6 mice. Residual virus titres of,2610
5 after 24 h, and ,1.5610
4 after 48 h were obtained following in vitro incubation of virus in the absence of cells. These control virus titres were comparable to that obtained from infected splenocyte and macrophage cultures of B6 mice, which confirms that little to no virus replication occurs in vitro in such cells of wt mice. This contrasts with high virus titres (100-200 folds higher) detected in IAa -/-splenocyte and macrophage cultures. To test whether in vitro cultures of I-Aa -/-macrophages can also support the replication of other alphaviruses, we evaluated virus replication of Ross River Virus, Sindbis and Bebaru at 24 and 48 h postinfection. As shown in figure 6B , macrophages from I-Aa -/-mice, but not from B6 mice, supported significant replication of all the alphaviruses tested at 48 h post infection. These data indicate that macrophages from I-Aa -/-mice, but not B6 mice, support replication of aSFV as well as other alphaviruses. It has been reported previously that in vitro aSFV infection of spleenic macrophages is associated with viral antigen presentation without release of infectious virus particles [25] . This block of viral replication/release is absent in macrophages of I-Aa -/-mice. In addition to virus replication experiments using ex-vivo cells, we generated tumor cell lines from I-Aa -/-and B6 mice that are not constitutively expressing MHC-II, for in vitro virus growth studies. We generated stable methyl colantherine induced I-Aa -/-and B6 fibroblast cell lines using a similar protocol to that used previously for the generation of MC57 cell line from the wild type B10 mice [26] . Triplicate flasks from I-Aa -/-and B6 cell lines were infected with aSFV using a MOI of 10 or 0.1 pfu/cell. Culture supernatants were harvested 24 h later and virus titres estimated using plaque assays. As shown in figure 7, significantly higher virus titres were obtained from the I-Aa -/-cell line compared to that of the B6 cell line with P values of 0.018 and 0.0018 for both 10 and 0.1 pfu, respectively, using unpaired student t test. This data confirms that the susceptibility of I-Aa -/-mice to virus infection is caused by an enhanced viral replication per se. These cell lines will be a vital tool to investigate the molecular and genetic basis of the mechanisms responsible for this unusual phenomenon. 
Susceptibility of I-Aa -/-mice to other virus infections
To test if this increased susceptibility of I-Aa -/-mice to alphavirus infections also applied to other virus infections, we tested viral replication of ectromelia (ECT) virus (poxviridae: DNA genome) and West Nile Virus (WNV) (Flaviviridae: RNA genome). I-Aa -/-and wild-type mice were infected i.v with 10 3 pfu/mouse of ECT-Moscow strain and spleens were harvested at day 3 p.i and virus titres estimated using plaque assays. The data clearly show significant enhancement of ECT replication in spleens of I-Aa -/-mice compared to wild-type controls with P value of 0.001 using unpaired student t test ( Figure 8A ). In addition, all I-Aa -/-mice designated to be sampled at day 6 post-infection had died prior to sampling. No-mortality occurred, as expected, in the wild-type control group. I-Aa -/-mice have been used previously to investigate the role of Ab responses in the recovery from virulent ECT infection [19] . While virus replication in I-Aa -/-mice was not evaluated. The researchers used s.c infection and reported that ECT-Moscow infection cause lethality (at days 12-25 postinfection) in primed and un-primed I-Aa -/-mice. We suspect that the route of administration may have influenced the early mortality detected in our model (day 6 post-infection using i.v). Importantly, our data clearly illustrates the significant increase in ECT replication in I-Aa -/-mice (2 log difference) compare to that of B6 mice. We also used the flavivirus WNV as an additional virus model and infected both I-Aa -/-and B6 mice i.v with 10 3 pfu/ mouse and estimated brain virus titres at day 8 p.i. Our data show a significant increase in the mean virus titres (4 log difference) in brain tissues from I-Aa -/-mice compared to B6 wild-type controls with P value of 0.023 using unpaired student t test ( Figure 8B ). These data indicate that I-Aa -/-mice support high levels of virus replication of a variety of virus types compared to that of wt B6 mice and this is observed with viruses that employ vastly different replication strategies.
In conclusion, we have uncovered a very unusual phenomenon in I-Aa -/-mice namely a vastly increased susceptibility to aSFV and other virus infections. This susceptibility is associated with enhanced virus replication (alphaviruses, flaviviruses, and orthopoxviruses) in a variety of tissues in vitro and in vivo. This increased viral susceptibility is unrelated to the MHC-II negative phenotype and appears not to involve a defect in the IFN-I mediated anti-viral response. Thus, our data indicate that I-Aa -/-mice may carry two distinctive and unrelated phenotypes: a defective MHC-II expression and an enhanced virus replication not related to defective antigen presentation. 
Materials and Methods

Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Australian National University. Experimental protocol was approved by the Animal Ethics Committee of the Australian National University, ACT, Australia (Permit Number: JIG47.06).
Animals
wild type C57BL/6J (B6) mice and syngeneic mice deficient in MHC-II molecules as a result of a defective Ab gene (I-Ab -/-) [6] , a disrupted Aa gene (I-Aa -/-) [7] , a complete deletion of Aa and Ab locus (I-Aa/b -/-) [8] , and IFN-a receptor knockout (IFN-IR -/-) [27] were used in this study. Throughout this study, 10-week-old female mice were used. Mice were bred under specific pathogenfree conditions and supplied by the Animal Breeding Facilities at the John Curtin School of Medical Research, Australian National University.
Cells and viruses
Vero (African green monkey kidney) and BHK (baby hamster kidney) were originally obtained from the American Type Culture Collection (ATCC). In addition, de novo methylcolantherine induced I-Aa -/-and B6 fibroblast cell lines were prepared as has Enhanced Virus Replication in MHC-II Knockout Mice PLOS ONE | www.plosone.orgbeen described [26] . All cells were maintained in Eagle's minimal essential medium (EMEM) plus 5% foetal calf serum (FCS) and grown at 37uC in a humidified conditions with 5% CO 2 .
Working stocks of avirulent SFV (strain A7) were prepared by infecting semi-confluent BHK cell monolayers at a multiplicity of 0.5 pfu per cell. Infected cells were incubated for 24 h and culture supernatants harvested, centrifuged at 1200 g for 4 min to remove cell debris and stored in single-use aliquots at 280uC. Virus titre determined by plaque assay on Vero cells and the titer of the working stocks of aSFV was 1610 8 pfu/mL. Other alphaviruses (Ross River virus, Sindbis virus, and Bebaru), ectromelia virus (orthopoxvirus) and West Nile Virus (Flavivirus), from previously published work [28] [29] [30] , have also been used in few experiments. For inactivated SFV, virus stocks were subject to 1.3610 6 Rad of gamma-irradiation (137Cs source at CSIRO-Canberra) and virus sterility was confirmed by lack of plaque formation on vero cells.
Plaque assay
Virus titres were estimated by plaque formation on semiconfluent monolayers of Vero cells as previously described [31] . Briefly, samples were serially diluted on ice in HBSS, pH 7.6, containing 0.2% BSA, and cells inoculated in duplicate with 0.1 ml aliquots of the diluted samples. Adsorption was for 1 h at 37uC followed by the addition of an agar overlay medium. After 48 h incubation at 37uC, cells were fixed with 5% paraformaldehyde (BDH chemicals, Aust.) for 1 h. Over-layers were removed, and fixed cells were stained with 0.2% crystal violet in ddH 2 O. The stain was aspirated and plaques counted.
For virus determination in infected mouse tissues, animals were sacrificed at a given time post-infection, tissues were aseptically removed, snap-frozen in liquid nitrogen or dry ice, and stored at 270uC. 10% (weight/volume) tissue suspensions in ice-cold HBSS (pH 7.6) containing 0.2% BSA were homogenized, clarified by centrifugation (18,0006g for 5 min at 4uC), and supernatants were stored in aliquots at 280uC. The limit of virus detection by plaque assay in tissues and serum samples of infected mice was 10 2 pfu/g or ml, respectively. In addition, brain, spleen, and muscle tissues from uninfected animals were homogenised in the presence of a known amount of virus and used as controls. Plaque titration indicated no loss of virus titers due to tissue components released during homogenisation. Virus determination for ECTV and WNV was carried out as previously described [29, 30] .
IFN-a levels in sera
Sera from SFV-infected B6 and I-Aa -/-mice were collected at day 1 p.i. (3 mice/strain) and tested for IFN-a levels using a sandwich ELISA kit according to the manufacturer's instructions (US Biological). For each experiment, a standard curve in the range of 0 2500 pg/ml IFN-a was generated and used to estimate the concentration of serum IFN-a of tested samples. Detection limit for IFN-a was 12.5 pg/ml.
Flow cytometric analysis
Spleens from infected and control mice were harvested and red cell-depleted single cell suspensions prepared. Lymphocytes (1610 6 ) were stained using fluorescent-conjugated anti-CD3, -CD4, -CD8, -CD19, -B220, -CD69, and -CD86 specific Abs (BD Pharmingen) and cell surface expression of these markers was assessed by flow cytometry using BD LSR II (BD Biosciences, Australia). In addition, cell surface expression levels of IFN-I receptor on splenocytes from B6 and I-Aa -/-mice were assessed by flow cytometry using BD LSR II (BD Biosciences, Australia) using I-Ab specific Abs (BD Pharmingen). Dead cells were labeled with 7-aminoactinomycin D (Sigma-Aldrich) and Fc receptors were blocked by the addition of anti-mouse CD16/CD32 (Fc III/II receptor) Ab (BD Pharmingen). Fc receptor Ab and 7-aminoactinomycin D were added before the addition of cell subpopulationand activation marker-reactive Abs.
Bone Marrow Chimeras
Females B6 and I-Aa -/-mice were lethally irradiated with 950 Rad from a 137 Cs source (CSIRO-Canberra) at 6 weeks of age, and reconstituted, as previously described [32] , with 5610 6 bone marrow cells. Bone marrow chimeras were treated with antibiotics (Neomycin and Polymyxin B sulfate) for 3 weeks post-reconstitution. 2 weeks later (5 weeks post-reconstitution), 2 mice from each group were sacrificed and splenocytes were stained using fluorescent-conjugated anti-CD19 and I-Ab specific Abs (BD Pharmingen) and cell surface expression of MHC-II on CD19 + cells was assessed using flow cytometry using BD LSR II (BD Biosciences, Australia). The remaining mice were injected i.v with 10 3 pfu/mouse of aSFV and various tissues were harvested at predetermined time points to test for virus titers using plaque assay.
Statistical analysis
Data were expressed as mean 6 standard error of means (SEM) and analysed using a two-tailed student t test. A p-value of,0.05 was deemed significant.
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